BioCentury | Aug 16, 2012
Distillery Therapeutics

Indication: Neurology

...include developing a long-acting, amyloid-based compound and evaluating its effects in models of progressive MS. Cardinal Therapeutics Inc....
...5(32); doi:10.1038/scibx.2012.845 Published online Aug. 16, 2012 Covered by issued and pending patents; licensed to Cardinal Therapeutics...
BioCentury | Aug 16, 2012
Targets & Mechanisms

Amyloids for inflammation

...b-amyloid peptides can reduce inflammation and reverse paralysis in mouse models of multiple sclerosis. 1 Cardinal Therapeutics Inc....
...Science Translational Medicine . "Our work represents a contrarian therapeutic opportunity, and at this stage Cardinal Therapeutics...
...move the science forward," said Steinman, corresponding author on the paper and a cofounder of Cardinal Therapeutics...
BioCentury | Mar 1, 2012
Distillery Therapeutics

Indication: Inflammation

...March 1, 2012 Use of HSPB5 for treating inflammatory disorders is patented; exclusively licensed to Cardinal Therapeutics Inc....
Items per page:
1 - 3 of 3
BioCentury | Aug 16, 2012
Distillery Therapeutics

Indication: Neurology

...include developing a long-acting, amyloid-based compound and evaluating its effects in models of progressive MS. Cardinal Therapeutics Inc....
...5(32); doi:10.1038/scibx.2012.845 Published online Aug. 16, 2012 Covered by issued and pending patents; licensed to Cardinal Therapeutics...
BioCentury | Aug 16, 2012
Targets & Mechanisms

Amyloids for inflammation

...b-amyloid peptides can reduce inflammation and reverse paralysis in mouse models of multiple sclerosis. 1 Cardinal Therapeutics Inc....
...Science Translational Medicine . "Our work represents a contrarian therapeutic opportunity, and at this stage Cardinal Therapeutics...
...move the science forward," said Steinman, corresponding author on the paper and a cofounder of Cardinal Therapeutics...
BioCentury | Mar 1, 2012
Distillery Therapeutics

Indication: Inflammation

...March 1, 2012 Use of HSPB5 for treating inflammatory disorders is patented; exclusively licensed to Cardinal Therapeutics Inc....
Items per page:
1 - 3 of 3